Indegene (BOM:544172) FCF Margin % : 0.00% (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Indegene FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Indegene's Free Cash Flow for the three months ended in Mar. 2025 was ₹0 Mil. Indegene's Revenue for the three months ended in Mar. 2025 was ₹7,556 Mil. Therefore, Indegene's FCF Margin % for the quarter that ended in Mar. 2025 was 0.00%.

As of today, Indegene's current FCF Yield % is 2.98%.

The historical rank and industry rank for Indegene's FCF Margin % or its related term are showing as below:

BOM:544172' s FCF Margin % Range Over the Past 10 Years
Min: 4.83 Med: 15.67 Max: 19.19
Current: 14.51

During the past 5 years, the highest FCF Margin % of Indegene was 19.19%. The lowest was 4.83%. And the median was 15.67%.

BOM:544172's FCF Margin % is ranked better than
85.29% of 673 companies
in the Healthcare Providers & Services industry
Industry Median: 2.69 vs BOM:544172: 14.51

Indegene FCF Margin % Historical Data

The historical data trend for Indegene's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene FCF Margin % Chart

Indegene Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

FCF Margin %

15.67

16.36

4.83

19.19

14.51

Indegene Quarterly Data
	Mar21	Mar22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Margin %	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Indegene's FCF Margin %

For the Health Information Services subindustry, Indegene's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indegene's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Indegene's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Indegene's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Indegene FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Indegene's FCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2025 )	/	Revenue (A: Mar. 2025 )
	=	4119	/	28393
	=	14.51 %

Indegene's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	0	/	7556
	=	0.00 %

Indegene FCF Margin % Related Terms

Thank you for viewing the detailed overview of Indegene's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Indegene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (BOM:544172) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

INDGN:India

Address

Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045

Website

https://www.indegene.com

Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines